EMPERY ASSET MANAGEMENT, LP Medicenna Therapeutics Corp. Transaction History

EMPERY ASSET MANAGEMENT, LP portfolio value:

$489,000
portfolio value

Medicenna Therapeutics Corp. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 589.31K shares 489K $0.83 589.31K